Drug intelligence / Profile preview

HisTAC

Development stage
Preclinical
Lead developer
University of Florida
Modality
PROTACs (E3 ligase recruitment) → Targeted Protein Degraders (TPDs) → Small Molecules, Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
01

Overview

HisTAC (polyHis-targeting chimera) is a ligand-independent targeted protein degradation (TPD) platform designed to degrade proteins of interest (POIs) that have been engineered with a polyhistidine tag. The system utilizes a nickel-nitrilotriacetic acid (Ni2+-NTA) moiety to bind the polyhistidine tag on the target protein and a separate ligand to recruit an E3 ubiquitin ligase, such as Cereblon (CRBN) or Von Hippel-Lindau (VHL). This proximity-induced approach facilitates the ubiquitination and subsequent proteasomal degradation of the tagged protein. HisTAC is particularly useful for studying traditionally undruggable targets or proteins lacking high-affinity small-molecule ligands, as it bypasses the need for a specific POI-binding ligand. It has demonstrated efficacy in degrading His-tagged versions of BRD4 and the RNA-binding protein PSPC1 in cellular models.

Other names
polyHis-targeting chimeraspolyhistidine-directed degraderpolyhistidine-targeting chimeras
02

Targets

VHL (Von Hippel–Lindau tumor suppressor protein)CRBN (Cereblon)

Beyond the preview

Go deeper on HisTAC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HisTAC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call